Biodegradation, biodistribution and toxicity of chitosan

Area of Science:

• Biomaterials Science
• Polymer Chemistry
• Pharmacology

Background:

• Chitosan is a natural polysaccharide with significant interest in biomedical applications.
• Its biocompatibility and chemical versatility (-NH2 groups, variable molecular weights) enable diverse formulations and scaffolds.
• Despite extensive research, chitosan lacks FDA approval for drug delivery, limiting its commercial use.

Purpose of the Study:

• To review biological properties influencing the safe use of chitosan in drug delivery.
• To critically assess research on chitosan's biodistribution, biodegradation, and toxicology.
• To discuss chitosan's potential as a Generally Regarded As Safe (GRAS) material.

Main Methods:

• Literature review of scientific studies on chitosan.
• Critical analysis of research data on chitosan's biological profiles.
• Synthesis of information regarding safety and regulatory aspects.

Main Results:

• Chitosan encompasses a diverse group of chemical entities with varying biological behaviors.
• Biodistribution, biodegradation, and toxicological profiles differ significantly among chitosan types.
• Limited data exists on standardized safety assessments for regulatory approval.

Conclusions:

• The heterogeneity of chitosan necessitates specific safety evaluations for each application.
• Establishing clear safety guidelines is crucial for advancing chitosan in drug delivery.
• Further research is required to support chitosan's GRAS status and facilitate FDA approval.